Crawford Fund Management, LLC Adaptive Biotechnologies Corp Transaction History
Crawford Fund Management, LLC
- $396 Billion
- Q2 2024
A detailed history of Crawford Fund Management, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Crawford Fund Management, LLC holds 40,500 shares of ADPT stock, worth $186,705. This represents 0.04% of its overall portfolio holdings.
Number of Shares
40,500Holding current value
$186,705% of portfolio
0.04%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ADPT
# of Institutions
187Shares Held
152MCall Options Held
8.4KPut Options Held
56K-
Viking Global Investors LP30MShares$138 Million0.43% of portfolio
-
Rubric Capital Management LP New York, NY14MShares$64.5 Million1.5% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$53.8 Million0.0% of portfolio
-
Matrix Capital Management Company, LP Waltham, MA11.6MShares$53.3 Million0.32% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.4MShares$52.6 Million0.38% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $659M
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...